|
Concord Biotech Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
17000.13 Cr.
|
P/BV
|
13.18
|
Book Value (Rs.)
|
123.31
|
|
52 Week High/Low (Rs.)
|
1725/900
|
FV/ML
|
1/1
|
P/E(X)
|
70.81
|
|
Bookclosure
|
|
EPS (Rs.)
|
22.95
|
Div Yield (%)
|
0.42
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR |
| FaceValue | 1.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 1046.16 | 95.11 |
| | | |
| EQUITIES AND LIABILITIES | | |
| SHAREHOLDER'S FUNDS | | |
| Equity Share Capital | 10.46 | 9.51 |
| Total Share Capital | 10.46 | 9.51 |
| | | |
| Reserves and Surplus | 1279.54 | 1093.71 |
| Total Reserves and Surplus | 1279.54 | 1093.71 |
| Total Shareholders Funds | 1290.00 | 1103.22 |
| | | |
| NON-CURRENT LIABILITIES | | |
| Long Term Borrowings | 6.24 | 31.25 |
| Deferred Tax Liabilities [Net] | 23.44 | 20.97 |
| Other Long Term Liabilities | 0.16 | 0.31 |
| Long Term Provisions | 2.30 | 1.87 |
| Total Non-Current Liabilities | 32.14 | 54.40 |
| | | |
| CURRENT LIABILITIES | | |
| Short Term Borrowings | 25.00 | 29.34 |
| Trade Payables | 93.80 | 83.11 |
| Other Current Liabilities | 45.57 | 40.98 |
| Short Term Provisions | 27.48 | 1.75 |
| Total Current Liabilities | 191.84 | 155.17 |
| | | |
| Total Capital And Liabilities | 1513.98 | 1312.79 |
| | | |
| ASSETS | | |
| NON-CURRENT ASSETS | | |
| Tangible Assets | 592.78 | 569.40 |
| Intangible Assets | 0.20 | 3.58 |
| Capital Work-In-Progress | 172.70 | 74.16 |
| Fixed Assets | 765.68 | 647.13 |
| Non-Current Investments | 0.12 | 0.26 |
| Other Non-Current Assets | 20.48 | 32.74 |
| Total Non-Current Assets | 786.28 | 680.13 |
| | | |
| | | |
| CURRENT ASSETS | | |
| Current Investments | 136.93 | 73.47 |
| Inventories | 212.31 | 195.12 |
| Trade Receivables | 273.76 | 232.17 |
| Cash And Cash Equivalents | 43.45 | 88.93 |
| OtherCurrentAssets | 61.25 | 42.97 |
| Total Current Assets | 727.70 | 632.67 |
| | | |
| Total Assets | 1513.98 | 1312.79 |
| | | |
| OTHER INFORMATION | | |
| | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | |
| Contingent Liabilities | 26.59 | 91.70 |
| | | |
| BONUS DETAILS | | |
| Bonus Equity Share Capital | 7.85 | 6.90 |
| | | |
| NON-CURRENT INVESTMENTS | | |
| Non-Current Investments Quoted Market Value | 0.12 | 0.26 |
| | | |
| CURRENT INVESTMENTS | | |
| Current Investments Quoted Market Value | 136.93 | 73.47 |